Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19

At least since March 2020, the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic and the multi-organ coronavirus disease 2019 (COVID-19) are keeping a firm grip on the world. Although most cases are mild, older patients and those with co-morbidities are at increased risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schumann, Sara, Kaiser, Astrid, Nicoletti, Ferdinando, Mangano, Katia, Fagone, Paolo, van Wijk, Eduard, Yan, Yu, Schulz, Petra, Ludescher, Beate, Niedermaier, Michael, von Wegerer, Joerg, Rauch, Pia, Setz, Christian, Schubert, Ulrich, Brysch, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699954/
https://www.ncbi.nlm.nih.gov/pubmed/33233817
http://dx.doi.org/10.3390/ijms21228803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699954/
https://www.ncbi.nlm.nih.gov/pubmed/33233817
http://dx.doi.org/10.3390/ijms21228803

Ejemplares similares